Cargando…
Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression
Only scarce data on liver steatosis in children with chronic hepatitis B and C (CHB and CHC) are available. The objective of this study was to evaluate the prevalence, predictors, and impact of hepatic steatosis on children with CHB and CHC. A total of 78 patients aged 11.5 ± 3.4 years were included...
Autores principales: | Pokorska-Śpiewak, Maria, Kowalik-Mikołajewska, Barbara, Aniszewska, Małgorzata, Pluta, Magdalena, Walewska-Zielecka, Bożena, Marczyńska, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279083/ https://www.ncbi.nlm.nih.gov/pubmed/28099338 http://dx.doi.org/10.1097/MD.0000000000005832 |
Ejemplares similares
-
The influence of hepatitis B and C virus coinfection on liver histopathology in children
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2014) -
Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017) -
Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017) -
Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest – comparison with histopathological assessment
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017) -
Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2021)